{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:19Z","timestamp":1792788499807,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Research Council for Health of the Academy of Finland","award":["138566"],"award-info":[{"award-number":["138566"]}],"id":[{"id":"https:\/\/ror.org\/05k73zm37","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Council for Health of the Academy of Finland","award":["266498"],"award-info":[{"award-number":["266498"]}],"id":[{"id":"https:\/\/ror.org\/05k73zm37","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Council for Health of the Academy of Finland","award":["273790"],"award-info":[{"award-number":["273790"]}],"id":[{"id":"https:\/\/ror.org\/05k73zm37","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Council for Health of the Academy of Finland","award":["218129"],"award-info":[{"award-number":["218129"]}],"id":[{"id":"https:\/\/ror.org\/05k73zm37","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union\u2019s Seventh Framework Programme","award":["273669"],"award-info":[{"award-number":["273669"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.tox.2015.03.001","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T12:05:19Z","timestamp":1425557119000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model"],"prefix":"10.1016","volume":"331","author":[{"given":"Tuomas","family":"Komulainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Lodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetta","family":"Hinttala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Bolszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Pietil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peppi","family":"Koivunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Hakkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Poulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Morten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Uusimaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2015.03.001_bib0005","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bcp.2009.10.011","article-title":"Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis","volume":"79","author":"Aires","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2015.03.001_bib0010","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2015.03.001_bib0015","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/0006-2952(82)90392-6","article-title":"Inhibition by valproic acid of pyruvate uptake by brain mitochondria","volume":"31","author":"Benavides","year":"1982","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2015.03.001_bib0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.taap.2006.12.013","article-title":"Mitochondrial abnormalities \u2013 a link to idiosyncratic drug hepatotoxicity?","volume":"220","author":"Boelsterli","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2015.03.001_bib0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.46.2.465","article-title":"Valproic acid hepatic fatalities. III. U.S. experience since 1986","volume":"46","author":"Bryant","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.tox.2015.03.001_bib0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-0270(00)00340-X","article-title":"MitoTracker labeling in primary neuronal and astrocytic cultures: influence of mitochondrial membrane potential and oxidants","volume":"104","author":"Buckman","year":"2001","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.tox.2015.03.001_bib0035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/jnnp.48.7.639","article-title":"A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy","volume":"48","author":"Callaghan","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tox.2015.03.001_bib0040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbabio.2008.10.007","article-title":"DNA polymerase gamma and mitochondrial disease: understanding the consequence of POLG mutations","volume":"1787","author":"Chan","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tox.2015.03.001_bib0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.fct.2014.04.002","article-title":"Acetaldehyde targets superoxide dismutase 2 in liver cancer cells inducing transient enzyme impairment and a rapid transcriptional recovery","volume":"69","author":"Clavijo-Cornejo","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tox.2015.03.001_bib0050","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/clinchem\/34.5.890","article-title":"Valproic acid and the liver","volume":"34","author":"Cotariu","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tox.2015.03.001_bib0055","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bbrc.2008.12.109","article-title":"Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells","volume":"379","author":"Cowell","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tox.2015.03.001_bib0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1034\/j.1399-3046.2000.00090.x","article-title":"Inappropriate liver transplantation in a child with Alpers\u2013Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure","volume":"4","author":"Delarue","year":"2000","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.tox.2015.03.001_bib0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1021\/cr040463d","article-title":"DNA polymerase gamma in mitochondrial DNA replication and repair","volume":"106","author":"Graziewicz","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.tox.2015.03.001_bib0070","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.31.11.1473","article-title":"Inhibitory effects of sodium valproate on oxidative phosphorylation","volume":"31","author":"Haas","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.tox.2015.03.001_bib0075","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MPG.0b013e31829ef4b4","article-title":"Reduced mitochondrial DNA content and heterozygous nuclear gene mutations in patients with acute liver failure","volume":"57","author":"Helbling","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.tox.2015.03.001_bib0080","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1373\/clinchem.2009.131441","article-title":"High-throughput assay to measure oxygen consumption in digitonin-permeabilized cells of patients with mitochondrial disorders","volume":"56","author":"Jonckheere","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tox.2015.03.001_bib0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.biochem.72.121801.161455","article-title":"DNA polymerase gamma: the mitochondrial replicase","volume":"73","author":"Kaguni","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.tox.2015.03.001_bib0090","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/toxsci\/kfq294","article-title":"Role of oxidative metabolism in the effect of valproic acid on markers of cell viability necrosis, and oxidative stress in sandwich-cultured rat hepatocytes","volume":"118","author":"Kiang","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2015.03.001_bib0095","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1528-1167.2006.00846.x","article-title":"Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003","volume":"47","author":"Koenig","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.tox.2015.03.001_bib0100","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2015.03.001_bib0105","article-title":"Valproic-acid induced hepatotoxicity in Alpers syndrome is associated with mPTP opening dependent apoptotic sensitivity in an iPSC model","author":"Li","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2015.03.001_bib0110","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbabio.2007.06.007","article-title":"Valproic acid metabolites inhibit dihydrolipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation","volume":"1767","author":"Luis","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tox.2015.03.001_bib0115","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","article-title":"Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants","volume":"97","author":"Marroquin","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2015.03.001_bib0120","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.12.2008.1303","article-title":"Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1)","author":"McFarland","year":"2009","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.tox.2015.03.001_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.tox.2015.03.001_bib0130","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.freeradbiomed.2005.08.038","article-title":"Nimesulide-induced hepatic mitochondrial injury in heterozygous Sod2(+\/\u2212) mice","volume":"40","author":"Ong","year":"2006","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.tox.2015.03.001_bib0135","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.beem.2012.05.003","article-title":"Cellular and molecular mechanisms of mitochondrial function","volume":"26","author":"Osellame","year":"2012","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tox.2015.03.001_bib0140","doi-asserted-by":"crossref","DOI":"10.1186\/1477-5956-7-20","article-title":"Mitochondrial proteomics on human fibroblasts for identification of metabolic imbalance and cellular stress","volume":"7","author":"Palmfeldt","year":"2009","journal-title":"Proteome Sci."},{"key":"10.1016\/j.tox.2015.03.001_bib0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/cyto.a.20033","article-title":"Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues","volume":"61","author":"Pendergrass","year":"2004","journal-title":"Cytometry"},{"key":"10.1016\/j.tox.2015.03.001_bib0150","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.tox.2015.03.001_bib0155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1007649815992","article-title":"Hepatotoxicity due to mitochondrial dysfunction","volume":"15","author":"Pessayre","year":"1999","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tox.2015.03.001_bib0160","first-page":"166","article-title":"Hepatoma HepG2 cells as a model for in vitro studies on mitochondrial toxicity of antiviral drugs: which correlation with the patient?","volume":"17","author":"Pinti","year":"2003","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.tox.2015.03.001_bib0165","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/0006-2952(92)90324-C","article-title":"In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA AT to the observed inhibitions","volume":"43","author":"Ponchaut","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2015.03.001_bib0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tiv.2012.01.020","article-title":"A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis","volume":"26","author":"Pourahmad","year":"2012","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tox.2015.03.001_bib0175","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.seizure.2010.01.002","article-title":"POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders","volume":"19","author":"Saneto","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.tox.2015.03.001_bib0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2011.10.033","article-title":"Superoxide dismutase 2 Val16Ala polymorphism is a risk factor for the valproic acid-related elevation of serum aminotransferases","volume":"99","author":"Saruwatari","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.tox.2015.03.001_bib0185","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1528-1157.1988.tb03757.x","article-title":"Fatal liver failure in 16 children with valproate therapy","volume":"29","author":"Scheffner","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.tox.2015.03.001_bib0190","first-page":"63","article-title":"Non-fatal and fatal liver failure associated with valproic acid","volume":"46","author":"Schmid","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.tox.2015.03.001_bib0195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0887-8994(97)00030-1","article-title":"Valproate-induced liver failure in one of two siblings with Alpers disease","volume":"16","author":"Schwabe","year":"1997","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.tox.2015.03.001_bib0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.tox.2015.03.001_bib0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/A:1005398516208","article-title":"Valproate inhibits the mitochondrial pyruvate-driven oxidative phosphorylation in vitro","volume":"20","author":"Silva","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.tox.2015.03.001_bib0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2014.03.006","article-title":"Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts","volume":"112","author":"Sitarz","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.tox.2015.03.001_bib0215","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/hep.23891","article-title":"Polymerase gamma gene POLG determines the risk of sodium valproate-induced liver toxicity","volume":"52","author":"Stewart","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2015.03.001_bib0220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.taap.2012.08.018","article-title":"Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes","volume":"264","author":"Surendradoss","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2015.03.001_bib0225","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/toxsci\/kfi184","article-title":"Valproic acid I: time course of lipid peroxidation biomarkers liver toxicity, and valproic acid metabolite levels in rats","volume":"86","author":"Tong","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2015.03.001_bib0230","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/toxsci\/kfi185","article-title":"Valproic acid II: effects on oxidative stress mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes","volume":"86","author":"Tong","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2015.03.001_bib0235","first-page":"2167","article-title":"Sodium valproate induces mitochondria-dependent apoptosis in human hepatoblastoma cells","volume":"124","author":"Wang","year":"2011","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.tox.2015.03.001_bib0240","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/fca.12.58","article-title":"Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species","volume":"8","author":"Webster","year":"2012","journal-title":"Future Cardiol."},{"key":"10.1016\/j.tox.2015.03.001_bib0245","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.tiv.2007.05.014","article-title":"Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells","volume":"21","author":"Westerink","year":"2007","journal-title":"Toxicol. In Vitro"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X15000529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X15000529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:28:58Z","timestamp":1759534138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X15000529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":49,"alternative-id":["S0300483X15000529"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2015.03.001","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2015.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}